IL6 and cancer: For example, using a nasopharyngeal carcinoma‐on‐a‐chip, the cytokine IL‐6 was identified as a key ECM component promoting cancer cell invasion and metastasis.[250] This can be exploited as a target to inhibit invasion and metastasis (intravasation in particular, which IL‐6 promotes).